Gravitate Health FHIR Implementation Guide, published by Gravitate Health Project. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/gravitate-health and changes regularly. See the Directory of published versions
Generated Narrative: SubstanceDefinition
Resource SubstanceDefinition "substance-lamivudine"
Profile: SubstanceDefinition (ePI)
identifier: id: 2T8Q726O95 (use: OFFICIAL)
version: 1
status: Active (PublicationStatus#active)
manufacturer: Organization/man-173fde4cb6b1018cb7ec8ab708d3961c "GLAXO WELLCOME, S.A."
| Type | Amount |
| exact () | 229.26 |
| MolecularFormula |
| C8H11N303S |
| Name | Type |
| (-)-1-((2R,5S)-2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL)CYTOSINE | Chemical Name (#x) |